The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments Christopher M. HillisAaron D. SchimmerMark A. Crowther Review Article 01 February 2015 Pages: 541 - 545
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach Meinolf KarthausThomas LehrnbecherDieter Buchheidt Review Article 20 February 2015 Pages: 547 - 556
Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial Christoph RölligKerstin Schäfer-EckardtUwe Platzbecker Original Article 05 November 2014 Pages: 557 - 563
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts Patricia FontJavier LoscertalesAna Villegas Original Article 13 November 2014 Pages: 565 - 573
Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma Jae Joon HanTae Min KimDae Seog Heo Original Article 24 October 2014 Pages: 575 - 581
Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with l-asparaginase-containing chemotherapy—a single institution experience Jian ZangChen LiMei Shi Original Article 21 November 2014 Pages: 583 - 591
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial Ines WasleGabriele GamerithMichael Mian Original Article 13 November 2014 Pages: 593 - 601
Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma Masaki HaraMinoru AndoKosaku Nitta Original Article 03 December 2014 Pages: 603 - 608
Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities? L. A. Guardado SánchezA. M. RedondoD. Caballero Original Article 25 December 2014 Pages: 609 - 616
Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation Seong Hyun JeongJoon Ho MoonSeok Jin Kim Original Article 03 December 2014 Pages: 617 - 625
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 109/L monoclonal lymphocytes better identifies subgroups with different outcomes A. C. OliveiraA. Fernández de SevillaE. González-Barca Original Article 05 December 2014 Pages: 627 - 632
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma Myron S. CzuczmanStephen KahanicNathan Fowler Original Article 30 January 2015 Pages: 633 - 641
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide I-Jun LauDean SmithKarthik Ramasamy Original Article 28 October 2014 Pages: 643 - 649
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry M. W. M. van der PoelS. OerlemansL. V. van de Poll-Franse Original Article 05 December 2014 Pages: 651 - 661
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation Eolia BrissotXavier CahuPatrice Chevallier Original Article 21 November 2014 Pages: 663 - 669
L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage Mohammad Reza DeyhimSeyed Alireza Mesbah-NaminNaser Amirizadeh Original Article 18 November 2014 Pages: 671 - 680
The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia M. Christina CoxArianna Di NapoliLuigi Ruco Letter to the Editor 06 September 2014 Pages: 681 - 682
Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma Takashi HigoTomomitsu MiyagakiMineo Kurokawa Letter to the Editor 10 September 2014 Pages: 683 - 685
Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy Junya KurodaShinsuke MizutaniMasafumi Taniwaki Letter to the Editor 12 September 2014 Pages: 687 - 689
Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma Alice C. JohnstonKikkeri NareshHolger W. Auner Letter to the Editor 05 October 2014 Pages: 691 - 692
Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient Masataka TaguchiYoshitaka ImaizumiYasushi Miyazaki Letter to the Editor 23 October 2014 Pages: 693 - 695
Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen Yok-Lam Kwong Letter to the Editor 04 September 2014 Pages: 697 - 699
Severe haemophagocytic lymphohistiocytosis triggered by a visceral leishmaniasis in a patient with a Rosai-Dorfman disease Thibault ComontGuillaume Martin-BlondelBruno Marchou Letter to the Editor 19 September 2014 Pages: 701 - 702
Unilateral hearing loss due to lymphocytosis and a contralateral putamen lesion Hilda WongYu-Yan HwangYok-Lam Kwong Letter to the Editor 07 October 2014 Pages: 703 - 704
Quality assessment of autologous haematopoietic blood progenitor cell grafting Francesco LanzaSandro DallorsoHans Johnsen Letter to the Editor 16 October 2014 Pages: 705 - 706
The first two cases of MYH9 disorders in Thailand: an international collaborative study Nongnuch SirachainanPatcharee KomwilaisakShinji Kunishima Letter to the Editor 15 November 2014 Pages: 707 - 709
Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis C. ArmstrongS. W. MaungH. Enright Letter to the Editor 25 November 2014 Pages: 711 - 712
Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome Laetitia MaugeAmélie PasseronLuc Darnige Letter to the Editor 09 November 2014 Pages: 713 - 715
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera Mohamad CherryMohamad KhawandanahAref Al-Kali Letter to the Editor 09 November 2014 Pages: 717 - 719
